BR0309808A - Combinação para o tratamento de distúrbios das vias aéreas - Google Patents

Combinação para o tratamento de distúrbios das vias aéreas

Info

Publication number
BR0309808A
BR0309808A BR0309808-7A BR0309808A BR0309808A BR 0309808 A BR0309808 A BR 0309808A BR 0309808 A BR0309808 A BR 0309808A BR 0309808 A BR0309808 A BR 0309808A
Authority
BR
Brazil
Prior art keywords
treatment
combination
airway disorders
airway
disorders
Prior art date
Application number
BR0309808-7A
Other languages
English (en)
Inventor
Guido Hanauer
Wolfgang Kromer
Stefan Postius
Wolfgang-Alexander Simon
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of BR0309808A publication Critical patent/BR0309808A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

"COMBINAçãO PARA O TRATAMENTO DE DISTúRBIOS DAS VIAS AéREAS". A presente invenção refere-se à combinação de inibidores de bomba de próton reversíveis e terapêuticos das vias aéreas para o tratamento de distúrbios das vias aéreas.
BR0309808-7A 2002-05-07 2003-05-03 Combinação para o tratamento de distúrbios das vias aéreas BR0309808A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02010305 2002-05-07
PCT/EP2003/004653 WO2003094967A2 (en) 2002-05-07 2003-05-03 New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders

Publications (1)

Publication Number Publication Date
BR0309808A true BR0309808A (pt) 2005-03-01

Family

ID=29414673

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0309808-7A BR0309808A (pt) 2002-05-07 2003-05-03 Combinação para o tratamento de distúrbios das vias aéreas

Country Status (17)

Country Link
US (1) US20050222193A1 (pt)
EP (1) EP1506016A2 (pt)
JP (1) JP2005528418A (pt)
KR (1) KR20050007476A (pt)
CN (1) CN1652822A (pt)
AU (1) AU2003227710A1 (pt)
BR (1) BR0309808A (pt)
CA (1) CA2484272A1 (pt)
EA (1) EA200401454A1 (pt)
HR (1) HRP20041160A2 (pt)
IL (1) IL164755A0 (pt)
MX (1) MXPA04011018A (pt)
NO (1) NO20045343L (pt)
PL (1) PL373287A1 (pt)
RS (1) RS95304A (pt)
WO (1) WO2003094967A2 (pt)
ZA (1) ZA200407896B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003043614A2 (en) * 2001-11-19 2003-05-30 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
EP1761157A1 (en) * 2004-04-30 2007-03-14 ALTANA Pharma AG Method of classifying gerd
CA2582300A1 (en) * 2004-10-05 2006-04-13 Altana Pharma Ag Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient
ES2675914T3 (es) 2010-11-16 2018-07-13 Texas Heart Institute Agonistas que mejoran la unión de células que expresan integrina a receptores de integrina
KR101873530B1 (ko) * 2012-04-10 2018-07-02 삼성전자주식회사 모바일 기기, 모바일 기기의 입력 처리 방법, 및 모바일 기기를 이용한 전자 결제 방법
JO3737B1 (ar) * 2015-07-21 2021-01-31 Athenex Therapeutics Ltd تركيبات علاجية من باكليتاكسيل تعطى عن طريق الفم ومثبط P-gp لعلاج السرطان

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8621425D0 (en) * 1986-09-05 1986-10-15 Smith Kline French Lab Compounds
CA2165192C (en) * 1993-07-02 2001-04-24 Hermann Amschler Fluoroalkoxy-substituted benzamides and their use as cyclic nucleotide phosphodiesterase inhibitors
DE19541689A1 (de) * 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
KR19980701690A (ko) * 1995-01-27 1998-06-25 리 카핀 엔도텔린 길항제로서의 치환 페닐 화합물
WO1996041626A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
CA2228953A1 (en) * 1995-09-26 1997-04-03 Takeda Chemical Industries, Ltd. Phosphorylamides, their preparation and use
SE9603725D0 (sv) * 1996-10-11 1996-10-11 Astra Ab New teatment
US6380222B2 (en) * 1996-10-11 2002-04-30 Astrazeneca Ab Use of an H+, K+-atpase inhibitor in the treatment of nasal polyps
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SI1003554T1 (en) * 1997-07-25 2005-04-30 Altana Pharma Ag Proton pump inhibitor in therapeutic combination with antibacterial substances
US6060472A (en) * 1998-04-06 2000-05-09 Apotex Inc. Thiadiazole compounds useful as inhibitors of H+ /K+ atpase
CA2341488A1 (en) * 1998-08-26 2000-03-09 Smithkline Beecham Corporation Therapies for treating pulmonary diseases
RS50145B (sr) * 1998-09-23 2009-03-25 Altana Pharma Ag., Tetrahidropiridoetri
GB9911017D0 (en) * 1999-05-13 1999-07-14 Zeneca Ltd Pharmaceutical compositions
MXPA02009551A (es) * 2000-03-29 2004-05-14 Altana Pharma Ag Profarmacos de derivados de imidazopiridina.
DE10062712A1 (de) * 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
AU2002227123A1 (en) * 2000-11-07 2002-05-21 Merck And Co., Inc. Method of treatment with a combination of a pde4 inhibitor and a leukotriene antagonist
WO2003043614A2 (en) * 2001-11-19 2003-05-30 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders

Also Published As

Publication number Publication date
EA200401454A1 (ru) 2005-06-30
IL164755A0 (en) 2005-12-18
PL373287A1 (en) 2005-08-22
CA2484272A1 (en) 2003-11-20
MXPA04011018A (es) 2005-01-25
KR20050007476A (ko) 2005-01-18
ZA200407896B (en) 2006-06-28
NO20045343L (no) 2004-12-06
JP2005528418A (ja) 2005-09-22
WO2003094967A2 (en) 2003-11-20
WO2003094967A3 (en) 2004-04-01
AU2003227710A1 (en) 2003-11-11
RS95304A (en) 2006-12-15
EP1506016A2 (en) 2005-02-16
CN1652822A (zh) 2005-08-10
US20050222193A1 (en) 2005-10-06
HRP20041160A2 (en) 2005-08-31

Similar Documents

Publication Publication Date Title
IS8485A (is) Notkun á setnum 2-amínótetralínum í fyrirbyggjandi meðferð á Parkinsons-veiki
CY2014005I1 (el) Τοπικα συστηματα παροχης γελης για την θεραπευτικη αντιμετωπιση των διαταραχων δερματος
DE50310516D1 (de) Fredericamycin-derivate
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
CR8380A (es) Metodos para preparar y utilizar compuestos novedosos de celulas madre y sus conjuntos
BR0207883A (pt) Composições de medicamentos à base de anticolenérgicos e inibidores de pde-iv
BRPI0408063A (pt) métodos e composições envolvendo mda-7
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
NZ533269A (en) Inhibitors of cytosolic phospholipase A2
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
BR0309808A (pt) Combinação para o tratamento de distúrbios das vias aéreas
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
BR0311180A (pt) Métodos para o tratamento de doenças e condições respiratórias utilizando um inibidor seletivo da inos
ITBO20030261A1 (it) Unita'di irraggiamento luminoso per diagnosi e cura di problemi cutanei.
BR0316475A (pt) Combinação sinergìstica que compreende roflumilast e (r,r)-formoterol
NO20045344L (no) Kombinasjon for behandling av luftveisforstyrrelser
BR0313204A (pt) Métodos para tratamento e prevenção de condições gastrointestinais
BRPI0414564A (pt) derivados de 2-alcilideno-19-nor-vitamina d para tratamento de fraqueza, lesão muscular ou sarcopenia
PL370839A1 (en) Use of proton pump inhibitors for the treatment of airway disorders
ATE545428T1 (de) Pik4cb involviert in der regulierung des energiestoffwechsels
NO20043774L (no) The use of devazenide as analgesic agent
BRPI0410305A (pt) composições de um inibidor seletivo de ciclooxigenase-2 á base de benzenossulfonamida ou metilsulfonilbenzeno e um agente colinérgico para o tratamento de redução de fluxo sangüìneo ou traumatismo do sistema nervoso central

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2051 DE 27/04/2010.